Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Quarterly results
Furiex Pharmaceuticals, Inc. (FURX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/17/2015 SC 13G/A RA CAPITAL MANAGEMENT, LLC reports a 0% stake in Furiex Pharmaceuticals, Inc.
02/17/2015 SC 13G/A Consonance Capital Management LP reports a 0% stake in Furiex Pharmaceutical, Inc
02/06/2015 SC 13G/A THOMPSON SIEGEL & WALMSLEY LLC reports a 0% stake in FURIEX PHARMACEUTICALS INC.
07/08/2014 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/07/2014 4 Forest Laboratories, LLC (10% Owner) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Bought 11,169,066 shares @ $95, valued at $1061.1M
Bought 11,169,066 shares @ $95, valued at $1061.1M
07/07/2014 SC 13D Magnetar Financial LLC reports a 10% stake in Furiex Pharmaceuticals, Inc.
07/07/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
07/07/2014 4 McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
07/07/2014 4 COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Disposed/sold 22,523 shares @ $0
Disposed/sold 26,000 options to buy @ $15, valued at $390k
Disposed/sold 37,944 options to buy @ $13.16, valued at $499.3k
07/07/2014 4 DIXON WENDY L (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Disposed/sold 7,160 shares @ $0
Disposed/sold 17,570 options to buy @ $9.11, valued at $160.1k
Disposed/sold 8,675 options to buy @ $13.94, valued at $120.9k
Disposed/sold 8,825 options to buy @ $13.45, valued at $118.7k
Disposed/sold 17,500 options to buy @ $18.22, valued at $318.9k
07/07/2014 4 Patel Sailash (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Disposed/sold 26,444 shares @ $0
Disposed/sold 26,360 options to buy @ $9.11, valued at $240.1k
Disposed/sold 20,000 options to buy @ $15, valued at $300k
Disposed/sold 29,644 options to buy @ $13.16, valued at $390.1k
Disposed/sold 8,294 options to buy @ $17.8, valued at $147.6k
07/07/2014 4 CORR PETER B (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Disposed/sold 8,447 shares @ $0
Disposed/sold 5,470 options to buy @ $9.11, valued at $49.8k
Disposed/sold 8,675 options to buy @ $13.94, valued at $120.9k
Disposed/sold 8,825 options to buy @ $13.45, valued at $118.7k
Disposed/sold 17,500 options to buy @ $18.22, valued at $318.9k
07/07/2014 4 Almenoff June Sherie (President) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
07/07/2014 4 Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
07/07/2014 4 DAVIS STEPHEN (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Disposed/sold 9,308 shares @ $0
07/03/2014 8-K Form 8-K - Current report
07/03/2014 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/01/2014 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Furiex Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger"
06/26/2014 4 Patel Sailash (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Sold 32,928 shares @ $104, valued at $3.4M
Exercised 32,928 options to buy @ $9.11, valued at $300k
06/26/2014 4 COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Sold 10,368 shares @ $104.12, valued at $1.1M
Exercised 10,368 options to buy @ $17.8, valued at $184.6k
06/23/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/20/2014 4 COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Sold 45,691 shares @ $104.11, valued at $4.8M
Exercised 45,691 options to buy @ $9.11, valued at $416.2k
06/18/2014 4 McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
06/17/2014 4 COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Sold 3,228 shares @ $104.25, valued at $336.5k
06/16/2014 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
06/12/2014 4 COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Sold 2,872 shares @ $104.63, valued at $300.5k
06/12/2014 4 McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
06/12/2014 4 Patel Sailash (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns: Sold 1,504 shares @ $104.68, valued at $157.4k
06/04/2014 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
05/28/2014 8-K Submission of Matters to a Vote of Security Holders
05/09/2014 10-Q Quarterly Report for the period ended March 31, 2014
05/09/2014 SC 13G MORGAN STANLEY reports a 5.3% stake in FURIEX PHARMACEUTICALS, INC.
05/07/2014 8-K Quarterly results
Docs: "Furiex Pharmaceuticals Reports First Quarter 2014 Financial Results",
"Presentation on May 6, 2014, regarding eluxadoline"
05/06/2014 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy